References
- American Association for Public Opinion Research. (2009). Standard definitions: Final dispositions of case codes and outcome rates for surveys. Retrieved from http://www.aapor.org/Content/NavigationMenu/ResourcesforResearchers/StandardDefinitions/StandardDefinitions2009new.pdf
- Austed, K. E., Avorn, J., Franklin, J. M., Kowal, M. K., Campbell, E. G. & Kesselheim, A. S. (2013). Changing interactions between physician trainees and the pharmaceutical industry: A national survey. Journal of General Internal Medicine, 28, 1064–71.
- Baumann, A. O., Deber, R. B. & Thompson, G. G. (1991). Overconfidence among physicians and nurses: The ‘micro-certainty, macro-uncertainty’ phenomenon. Social Science and Medicine, 32, 167–174.
- Brotzman, G. L. & Mark, D. H. (1993). The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. Journal of General Internal Medicine, 8, 30–34.
- Dawson, N. V., Connors, A. F., Speroff, T., Kemka, A., Shaw, P. & Arkes, H. R. (1993). Hemodynamic assessment in the critically ill: Is physician confidence warranted? Medical Decision Making, 13, 258–266.
- Food and Drug Administration (2014a). [Advertising submissions data]. Unpublished raw data.
- Food and Drug Administration (2014b). [Bad Ad Program data]. Unpublished raw data.
- Food, & Drug Administration. (2014c). Truthful prescription drug advertising and promotion. Retrieved from http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/drugmarketingadvertisingandcommunications/ucm209384.htm
- Hafferty, F. W. & Franks, R. (1994). The hidden curriculum, ethics teaching, and the structure of medical education. Academic Medicine, 69, 861–871.
- Kaphingst, K. A., DeJong, W., Rudd, R. E. & Daltroy, L. (2004). A content analysis of direct- to-consumer prescription drug advertisements. Journal of Health Communication, 9, 515–528.
- Kornfield, R., Donohue, J., Berndt, E. R. & Alexander, G. C. (2013). Promotion of prescription drugs to consumers and prescribers, 2001–2010. PLoS ONE, 8, e55504.
- Mansfield, P. R., Lexchin, J., Wen, L. S., Grandori, L., McCoy, C. P., Hoffman, J. R., … Jureidini, J. N. (2006). Educating health professionals about drug and device promotion: Advocates'recommendations. PLoS Medicine, 3, e451.
- McCormick, B. B., Tomlinson, G., Brill-Edwards, G. & Detsky, A. S. (2001). Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA, 286, 1994–1999.
- Mintzes, B. (2014). Educational initiatives for medical and pharmacy students about drug promotion: An international cross-sectional survey. Geneva, Switzerland: World Health Organization and Health Action International. Retrieved from http://www.haiweb.org/26012006/MRhaipromosurveyFINAL06.pdf
- Pharmaceutical Researchers and Manufacturers of America. (2009). Code on interactions with healthcare professionals. Retrieved from http://www.phrma.org/sites/default/files/pdf/phrma_marketing_code_2008.pdf
- Rosenthal, M. B., Ernst, E. R., Donoghue, J. M., Frank, R. G. & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New England Journal of Medicine, 346, 498–505.
- Ross, J. S. & Kravitz, R. L. (2013). Direct-to-consumer television advertising: Time to turn off the tube? Journal of General Internal Medicine, 28, 862–864.
- Sierles, F. S., Broadkey, A. C., Cleary, L. M., McCurdy, F. A., Mintz, M., Frank, F., … Woodard, J. L. (2005). Medical students’ exposure to and attitudes about drug company interactions: A national survey. JAMA, 294, 1034–1042.
- Tardif, L., Bailey, B., Bussieres, J.-F., Lebel, D. & Soucy, G. (2009). Perceived advantages and disadvantages of using drug samples in a university hospital center: A case study. Annals of Pharmacotherapy, 43, 57–63.
- Vinson, D. C., McCandless, B. & Hosokawa, M. C. (1993). Medical students’ attitudes toward pharmaceutical marketing: Possibilities for change. Family Medicine, 25, 31–33.
- Wilkes, M. S. & Hoffman, J. R. (2001). An innovative approach to educating medical students about pharmaceutical promotion. Academic Medicine, 76, 1271–1277.
- Yang, H. & Thompson, C. (2010). Nurses’ risk assessment judgements: A confidence calibration study. Journal of Advanced Nursing, 66, 2751–2760.
- Zipkin, D. A. & Steinmann, M. A. (2005). Interactions between pharmaceutical representatives and doctors in training: A thematic review. Journal of General Internal Medicine, 20, 777–786.